Virtual drug design platform to accelerate drug discovery

February 17, 2022
Business Services

The Cambridge Crystallographic Data Centre (CCDC) announced a strategic partnership with Dassault Systemes to advance bioscience innovation with a cloud-based …

Invitae launches first CE-IVD cancer testing kits in Europe

February 16, 2022
Research and Development

Invitae, leading medical genetics company, announced the availability of FusionPlex Dx and LiquidPlex Dx in Europe.With this development, the company …

AstraZeneca COVID-19 vaccine’s short shelf life inhibits rollout to poor countries

February 16, 2022
Research and Development

According to officials and WHO documents, the short shelf life of the AstraZeneca COVID-19 vaccine is complicating the rollout to …

Scientists possibly cure HIV in first-time breakthrough for virus

February 16, 2022
Research and Development

An American research team appear to have cured HIV in a woman for the first time, making her the third …

Moderna launch Omicron-specific UK vaccine study

February 16, 2022
Research and Development

Around 3,000 British volunteers are being sought to take part in a new study for Moderna’s Omicron booster vaccine. The …

Astellas and Seagen announce results of study into muscle-invasive bladder cancer

February 15, 2022
Medical Communications

Astellas Pharma and Seagen announced the initial results from Cohort H of their EV-103 trial. This investigated PADDCEV (enfortumab vedotin-ejfv) …

Genuv partners with Aiforia for AI-Powered Drug Screening Platform

February 15, 2022
Manufacturing and Production

Genuv has announced an agreement with the medical technology company Aiforia Technologies, to add Aiforia’s AI deep learning for medical …

NICE recommends new diagnostic devices for men with suspected prostate cancer

February 15, 2022
Medical Communications

NICE have recommended four new diagnostic devices for men with suspected prostate cancer, which reduce the chances of biopsy related …

‘Game-changing’ South African mRNA hub set to be a foundation for self-reliance

February 15, 2022
Manufacturing and Production

WHO officials have visited a number of public and private sector partners that are collaborating to develop and build WHO’s …

FDA approves Eversense CGM system for use for up to six months

February 14, 2022
Sales and Marketing

The FDA has approved Senseonics’ Eversense E3 CGM System, which includes proprietary sacrificial boronic acid (SBA) technology to extent longevity …

AbbVie submits applications for treatment of chronic disease

February 14, 2022
Sales and Marketing

AbbVie has announced the submission of applications seeking the approval of upadacitinib, (RINVOQ®, 15 mg once daily) for the treatment …

Gilead’s HIV treatment demonstrates high efficacy and viral suppression at five years

February 14, 2022
Sales and Marketing

Gilead Sciences has announced the presentation of cumulative five-year results from two Phase III studies of Biktarvy. The new, long-term …

First UK Lassa fever death in over a decade

February 14, 2022
Sales and Marketing

A patient in Bedfordshire has died from a confirmed case of Lassa fever, the UK Health Security Agency (UKHSA) has …

Risk of new heart problems raised after COVID-19

February 11, 2022
Medical Communications

A large study has found that long after recovery from COVID-19, people continue to face significantly higher risks for new …

Novavax COVID-19 vaccine meets trial endpoints

February 11, 2022
Medical Communications

Novavax has announced that NVX-CoV2373, its recombinant nanoparticle protein-based COVID-19 vaccine, achieved its primary effectiveness endpoint in the paediatric expansion …

Sickest patients face record long waits for hospital bed

February 11, 2022
Medical Communications

According to NHS data, the sickest patients are facing record long waits for a bed upon admission to hospital in …

Researchers find molecular treatment works against metastatic cancer spread to the brain

February 11, 2022
Medical Communications

According to a study published in Clinical Cancer Research, scientists at Mount Sinai conducting clinical trials of a drug targeting …

First biologic medicine approved in China for lupus

February 10, 2022
Business Services

Nearly half a million people in China have systematic lupus erythematosus (SLE), and more than have of this number will …

COVID-19 isolation law could end this month in England

February 10, 2022
Business Services

Boris Johnson has said that all remaining COVID-19 restrictions in England – including the legal rule to self-isolate – could …

AI support tool aims to change skin cancer treatment in the NHS

February 10, 2022
Business Services

Chelsea and Westminster Hospital NHS Foundation Trust has announced the expansion of its partnership with Skin Analytics, with the roll …

The Gateway to Local Adoption Series

Latest content